Subscribe to Newsletter


Reset Filter
You have a filtered search result

229 search results for ‘*’

Business & Regulation Standards & Regulation

The Ethical Issues of Advanced Medicine

| Sumukhi Sreevatsan | 3 min read

How do we encourage the development of new cell and gene therapies without compromising our ethics?

Business & Regulation Digital Technologies

Can AI Tackle Drug Shortages?

| Jo Varshney | 4 min read

Exploring the role of AI in helping bring more medicines to market.

Manufacture Technology and Equipment

MES: Just What the Doctor Ordered

| Nic Azad | 3 min read

How manufacturing execution systems can help with sustainability strategies

Business & Regulation Profession

Hello – From Women in Pharma

| Miriam Kenrick, Sarah Sowerby | 10 min read

The Women in Pharma network aims to inspire, empower and shape the pharma industry to better serve women. Meet the minds behind the mission.

Discovery & Development Drug Delivery

The VLP Promise

| Nicholas (Nik) Barbet | 4 min read

Here’s why virus-like particles could open a new chapter in combating disease.

Discovery & Development Drug Discovery

Nobel Prize for mRNA COVID-19 Vaccine Technology

| Stephanie Sutton | 7 min read

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.

Manufacture Advanced Medicine

Viable Viruses

| Neil Ward | 4 min read

Could non-pathogenic viruses provide an unrejectable therapeutic target?

Discovery & Development Drug Discovery

The FLEET of Hope

| Robert H Cichewicz | 3 min read

Fungal infections and antifungal resistance are a significant problem; here’s one approach to consider

Manufacture Bioprocessing - Upstream & Downstream

Planes, Trains, and Autologous Therapies

| Sumukhi Sreevatsan | 3 min read

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.

Business & Regulation Standards & Regulation

FDA Warning Letters: September 2023 Edition

| Stephanie Sutton | 4 min read

A look at cGMP deviations in recent warning letters, including manufacturing conducted in corridors and equipment uncleaned for 14 years.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine